National Pharmaceutical Council

Latest from National Pharmaceutical Council

Dr Matthew Reynolds Addresses Pre-, Postpandemic Implications for Real-world Data and Research

May 20, 2021

Matthew Reynolds, PhD, vice president of real-world evidence at IQVIA, discusses findings of a recent paper with the National Pharmaceutical Council on how COVID-19 affected real-world data and research, as well as implications for future studies.

How Shared Decision-Making, Patient Decision Aids Impact Cost, Utilization

May 14, 2021

Panelists of a session at the Pharmacy Quality Alliance 2021 Annual Meeting explore how shared decision-making and patient decision aids can promote appropriate care and treatment adherence, as well as lower cost and utilization of health care services.

Dr Robert Dubois Details the Vital Importance of Increasing Healthcare Spending Discussions

November 01, 2019

Discussions around healthcare spending have been ignored for decades, but Robert Dubois, MD, PhD, chief science officer and executive vice president at National Pharmaceutical Council, believes we have the ability to start those discussions now.

ISPOR 2019: On Location Interviews, Day 1

April 23, 2019

Interviews with Joey Mattingly, PharmD, MBA, of the University of Maryland School of Pharmacy, and Robert Dubois, MD, PhD, of the National Pharmaceutical Council from day 1 of the ISPOR 2019 annual meeting in New Orleans, Louisiana.

Getting Ready for the Use of Real-World Evidence

February 05, 2019

FDA has launched a process that will give real-world data generated outside clinical trials more importance than it’s had in the past—with implications for payers, drug companies, and most of all, patients.